|
An invitation to join the conversation here on Agoracom
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 21, 2018 10:08AM
|
|
Anacetrapib Officially Bites the Dust
|
7
|
Resverlogix Corp.
|
Oct 11, 2017 11:18PM
|
|
Anacetrapib/Reveal CETP Study results to be announced in August
|
3
|
Resverlogix Corp.
|
Jun 13, 2017 10:43AM
|
|
And we wait.....
|
7
|
Zenith Epigenetics
|
Jan 23, 2018 11:04AM
|
|
And we wait.......
|
5
|
Resverlogix Corp.
|
Jan 23, 2018 11:05AM
|
|
Angiochem receives $7.5 million in Series C financing
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 02, 2018 09:17AM
|
|
Angiochem's ANG1005 nearing start of Phase 3
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 21, 2016 03:45PM
|
|
Another apabetalone/COVID-19 connection
|
8
|
Resverlogix Corp.
|
Apr 20, 2021 05:39PM
|
|
Another application/indicati... for the compound libraries
|
2
|
Resverlogix Corp.
|
May 19, 2017 12:01PM
|
|
Another country listed on EU Clinical Trial Register for BETonMACE
|
8
|
Resverlogix Corp.
|
Dec 09, 2015 12:47PM
|
|
Another RVX-208 Poster at IAS 2015 May 26
|
2
|
Resverlogix Corp.
|
May 18, 2015 01:51PM
|
|
Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics
|
6
|
Resverlogix Corp.
|
Jun 12, 2017 07:36PM
|
|
Answers from IR
|
11
|
Resverlogix Corp.
|
Jun 07, 2018 11:05PM
|
|
Any catalysts in Q1 to awaken the masses?
|
5
|
Resverlogix Corp.
|
Jan 19, 2016 09:55PM
|
|
Any day now.......
|
3
|
Zenith Epigenetics
|
May 05, 2016 11:25AM
|
|
Anyone else find it odd......
|
8
|
Resverlogix Corp.
|
Aug 19, 2019 10:47AM
|
|
Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes
|
6
|
Resverlogix Corp.
|
May 08, 2020 02:20PM
|
|
Apabetalone and Alkaline Phosphatase
|
18
|
Resverlogix Corp.
|
Oct 12, 2019 08:31AM
|
|
Apabetalone and FXR
|
9
|
Resverlogix Corp.
|
Jun 27, 2018 04:55PM
|
|
Apabetalone and NAFLD
|
9
|
Resverlogix Corp.
|
Jun 29, 2020 10:00AM
|
